Glucagon-like peptide 1 (GLP-1) is an incretin hormone that reduces hyperglycemia, improves endothelial function, induce vasodilatory effects on arteries, and in clinical studies shown to reduce cardiovascular events, and improve cardiac function [6]. The gene discussed is GCG; the disease is Hyperglycemia.